Sofie CO.
Sterling, VA Doing business as IBA Molecular Part of Sofie Biosciences, Inc.
- UEI
- JV1AHJHGUGG3
- CAGE
- 09QR8
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Sofie Biosciences, Inc.
Parent
Z1ZFWF2N1YD4
- Sofie CO. JV1AHJHGUGG3
-
Sofie Biosciences, Inc.
Parent
Z1ZFWF2N1YD4
- SAM.gov registration date
- Physical address
- 21000 Atlantic Blvd # 730, Sterling, VA 20166, USA
- Website
- sofie.com
- Founded
- 2008
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Add maximum quantities limits to IDC contract. | Veterans Integrated Service Network 15 | $357,066 | |
| Pylarify f-18 dcfpyl | Veterans Integrated Service Network 15 | $1,172,834 | |
| Pet radiopharmaceuticals for buffalo VA medical center. | Veterans Integrated Service Network 2 | $624,017 | |
| Positron emission tomography (pet) radiopharmaceuticals. | Veterans Integrated Service Network 2 | $830,796 | |
| Radio-pharmaceutical for patient care. | Defense Health Agency | $21,863 |
About Sofie CO.
Sofie CO., doing business as IBA Molecular, is a for-profit subsidiary of Sofie Biosciences, Inc., headquartered in Sterling, Virginia, that manufactures and supplies positron emission tomography (PET) radiopharmaceuticals and molecular diagnostic imaging agents to the Department of Veterans Affairs, Defense Health Agency, and other federal healthcare agencies as a prime contractor on 99% of recent awards. The company operates primarily under full-and-open competition without set-aside designation, though it holds multiple total small business set-aside delivery orders from VA regional networks—notably a $5.864 million indefinite delivery contract with VISN 15 for PYLARIFY supply and a $1.361 million small business set-aside IDIQ with VISN 15 for PET/CT radiopharmaceuticals. The company's core capability centers on manufacturing, preparation, and delivery of FDA-approved PET imaging agents including PYLARIFY (piflufolastat F-18) for prostate cancer detection, NEURACEQ (florbetaben F-18) for Alzheimer's disease imaging, F-18 fluorodeoxyglucose (FDG) for oncology applications, and specialized gallium-68 and copper-64 radiopharmaceuticals for neuroendocrine tumor and positron emission tomography/MRI imaging.
VA regional networks dominate the customer base. The top five funding agencies account for 59% of combined potential value, led by VISN 2 (46 awards, $28.9 million), VISN 15 (24 awards, $21.7 million), the Defense Health Agency (71 awards, $19.1 million), Army Medical Command (4 awards, $13.3 million), and VISN 10 (14 awards, $11.4 million). Award volume shows relative stability over the past three years—29 awards each in 2023 and 2024, dropping to 27 in 2025 and 10 through mid-2026. The company faces a recompete cliff of 21 awards valued at $14.9 million completing within the next twenty-four months, primarily within VA networks. Sofie CO. places significant task-order activity under master blanket purchase agreements with the Defense Health Agency, including HT001421A0014 (30 task orders, $1.4 million combined value) and HT001424A0002 (20 task orders, $1.9 million combined value), and holds single-award IDIQs with multiple VA VISNs. Recent representative work includes a $1.172834 million total small business set-aside delivery order from VISN 15 for PYLARIFY F-18 DCFPYL awarded June 1, 2026; a $1.465 million delivery order from VISN 17 for PYLARIFY awarded September 1, 2025; a $1.388 million purchase order from VISN 4 for FDG and NEURACEQ radiopharmaceuticals awarded May 1, 2024; and a $1.115 million delivery order from VISN 2 for PET radiopharmaceuticals under an IDV awarded April 15, 2025.
The company maintains compliance with U.S. Nuclear Regulatory Commission and Food and Drug Administration requirements and operates manufacturing facilities in Sterling, Virginia, with specified delivery locations at individual VA medical centers and Army medical facilities. As a sub-recipient, Sofie CO. partners with Mayo Clinic on federal grant-funded clinical development work, including supply of GMP-grade Ga-68 generators and FAPI-46 precursor material for a pancreatic cancer imaging trial, and provides regulatory and manufacturing technical support to Mayo's radiopharmaceutical development programs. NAICS coding reflects pharmaceutical preparation manufacturing (293 awards), with PSC coding concentrated in drugs and biologicals (198 awards) and in vitro diagnostic substances (126 awards). The vendor's 455-award footprint across 22 federal agencies, with $160.4 million in combined potential value ($65 million obligated), positions it as an entrenched supplier to VA and DoD healthcare networks, particularly for specialized cancer and neurology imaging diagnostics where regulatory barriers and manufacturing complexity favor incumbent relationships.
Quick answers
What is Sofie CO.'s UEI?
Sofie CO.'s Unique Entity ID (UEI) in SAM.gov is JV1AHJHGUGG3.
What is Sofie CO.'s CAGE code?
Sofie CO.'s CAGE code is 09QR8.
What is Sofie CO.'s primary NAICS code?
Sofie CO.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Sofie CO. located?
Sofie CO.'s physical address in SAM.gov is 21000 Atlantic Blvd # 730, Sterling, VA 20166, USA.
Is Sofie CO. registered in SAM.gov?
Yes. Sofie CO.'s SAM.gov registration is active through September 8, 2027.
Who is Sofie CO.'s parent company?
Sofie CO. is part of Sofie Biosciences, Inc.
What is Sofie CO.'s most recent federal award?
Sofie CO.'s most recent federal contract award is Add maximum quantities limits to IDC contract (36C25526N0392), from Veterans Integrated Service Network 15, on September 1, 2026.
On GovTribe
See Sofie CO.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors